Table 1. Descriptive statistics for Brazil, Colombia, and Peru.
| Brazil | Colombia | Peru | |
|---|---|---|---|
| Pre-PCV period | January 2005 - February
2010 (5 years and 2 months) |
January 2005 - October
2011 (6 years and 10 months) |
January 2005 - July 2009
(4 years and 7 months) |
| Post-PCV period | March 2010 - December
2015 (5 years and 10 months) |
November 2011 -
December 2015 (4 years and 2 months) |
August 2009 -
December 2014 (5 years and 5 months) |
| Total number of J12-18 among children 2–23
months of age in the study period (coded as primary or non-primary causes of death) 1 |
16,303 | 4700 (primary only) | 6854 |
| Total number of J12-18 among children 2–23
months of age in the study period (coded as primary cause of death) 1 |
35,259 | 4700 | 5818 |
| Weighted average of PCV third dose coverage
in the last year of the study period |
91.7% in 2015 | 91.1% in 2015 | 81.8% in 2014 |
1These numbers are before filtering out regions with sparse data. The study periods include both pre- and post-PCV periods.
Abbreviation: PCV, pneumococcal conjugate vaccine.